Medlive Technology Co., Ltd. announced that Dr. Li Zhuolin has tendered his resignation as a non-executive director of the Company with effect from 14 April 2023 as he intended to devote more time to his other business commitments. The Board announced that Mr. Kazutaka Kanairo ("Mr. Kanairo") has been appointed as a non-executive Director of the Company with effect from 14 April 2023. Mr. Kazutaka Kanairo, aged 45, is the head of India & Southeast Asia business and director of global corporate development of M3 Inc. (a company listed on the Tokyo Stock Exchange (Stock Code: 2413.T) and one of the controlling shareholders of the Company).

Prior to joining M3 Inc. in March 2014, Mr. Kanairo worked at McKinsey & Company Inc. from April 2003 to August 2008, where his last position was associate. From July 2010 to February 2014, Mr. Kanairo worked at JPMorgan Securities Japan Co., Ltd. where his last position was associate. Mr. Kanairo has over twelve years of experience in M&A and corporate development and over eleven years of experience in management advisory.